[Development and application of NF-kappaB decoy oligodeoxynucleiotide].
Li
Li
L
Wu
Li-Ling
LL
D000818:Animals; D001665:Binding Sites / Q000235:genetics; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics; D009203:Myocardial Infarction / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000378:metabolism; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000235:genetics; D052247:Nitric Oxide Synthase Type II; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology*
D016328:NF-kappa B; D009838:Oligodeoxyribonucleotides; D018799:Intercellular Adhesion Molecule-1; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II